-Economic and Political Weekly The decision to reduce the powers of the drug pricing body goes against the interest of public health. The decision of the Government of India to withdraw the power of the National Pharmaceutical Pricing Authority (NPPA) to set price controls on drugs that are not on the National List of Essential Medicines (NLEM) raises questions on the Narendra Modi regime's commitment to people's welfare. One must ask if...
More »SEARCH RESULT
Total Matching Records found : 835
US to launch fresh review of India's patent regime -Sidhartha
-The Times of India NEW DELHI: Within days of Prime Minister Narendra Modi's return from the US, the US Trade Representative (USTR) has launched a fresh offensive against India's intellectual property rights (IPR) regime, a move that may lead to the government going slow on a bilateral dialogue with Washington. On Tuesday, USTR will launch what it calls an "out-of-cycle review" (OCR) of India's IPR regime, following a report released earlier this...
More »New hepatitis cure far too costly -Martin Khor
-Asia News Network A controversy is brewing over a new cure for hepatitis C because it is extremely expensive and patients in middle-income countries like Malaysia will find it way beyond their budget. There are an estimated 400,000 Malaysians with hepatitis C, but this is probably a significant under-estimate since many people are not aware that they have the virus. Worldwide, 170 million people live with the hepatitis C virus (HCV), and every...
More »For public health as political priority -Sujatha Rao
-The Hindu A systemic reform of the health sector in order to meet the key objectives of equity, efficiency and quality is long overdue. In this, the Central and State governments need to make interventions intelligently, decisively and strategically so that the poor reap the benefits How does Prime Minister Narendra Modi's focus on population, health and subjects like public hygiene, the facilitation of toilets and ensuring preventive health through yoga fit...
More »Basmati cess to fund Cancer care in Punjab -Neel Kamal
-The Times of India BATHINDA: Basmati brought to grain markets in Punjab will now contribute to the cause of Cancer treatment as the government has imposed a cess of 0.25% on this variety of rice from this season. Punjab marketing board authorities expect to collect around Rs 19 crore from this decision depending on the arrival of basmati in the market. State agencies are hopeful of basmati yield reaching 35-36 lakh tonnes this...
More »
